Angioedema Treatment Market [2022] In-Depth Analysis And Business Development Strategies Includes Top Players like Shire plc, CSL Limited, Pharming Group NV

Major players operating in the global angioedema treatment market are focused on approval and launch of new products to expand their product portfolio. For instance in 2014, Shire Canada Inc. received approval for its FIRAZYR (icatibant injection) in Canada. FIRAZYR is indicated for the treatment of acute attacks of HAE in adults with C1-esterase inhibitor deficiency. Similarly, in 2014, the U.S. Food and Drug Administration approved Pharming Group NV and Salix Pharmaceuticals, Ltd.’s RUCONEST (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg, indicated for the treatment of acute angioedema attacks in adult and adolescent patients with HAE.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1371

Global Angioedema Treatment Market: Drivers

Approval and launch of new products is expected to propel growth of the global angioedema treatment market over the forecast period. For instance, in 2017, European Commission approved label extension for FIRAZYR (icatibant injection) from Shire plc. extending its use to adolescents and children aged 2 years and older, with HAE caused by C1-esterase-inhibitor (C1-INH) deficiency.

Moreover, release of guidelines for the management of hereditary angioedema is also expected to propel growth of the global angioedema treatment market over the forecast period. For instance, in 2013, the World Allergy Organization provided guideline for the management of hereditary angioedema.

Market Trends

Europe is expected to witness significant growth in the global angioedema treatment market, owing to release of guidelines for the management of hereditary angioedema. For instance, in 2015, British Society for Allergy and Clinical Immunology provided a guideline for the management of chronic urticaria and angioedema.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1371

North America is also expected to witness significant growth in the global angioedema treatment market, owing to approval and launch of new products. For instance, in 2017, the U.S. Food and Drug Administration approved Haegarda, a C1 Esterase Inhibitor (Human) for subcutaneous administration indicated for the preventing hereditary angioedema (HAE) in adult and adolescent patients.

Global Angioedema Treatment Market: Competitive Landscape

Major players operating in the global angioedema treatment market include, BioCryst Pharmaceuticals, Inc., CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., Pharming Group NV, and Shire plc.

Global Angioedema Treatment Market: Key Developments

Major players operating in the global angioedema treatment market are focused on expansion of production capabilities to enhance their market share. For instance in January 2018, the U.S. Food and Drug Administration approved Shire plc’s technology transfer of CINRYZE (C1 esterase inhibitor [human] indicated for the treatment of HAE in teenagers and adults) drug product manufacturing process to Vienna, Austria manufacturing site.

Major players operating in the global angioedema treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2016, the U.S. Food and Drug Administration approved CSL Behring’s Berinert [C1 Esterase Inhibitor (Human)], indicated for the treatment of HAE attacks in pediatric patients.

Global Angioedema Treatment Market: Segmentation

By Condition Type:

• Allergic angioedema
• Drug-induced angioedema
• Idiopathic angioedema
• Hereditary angioedema (HAE)

By Drug Type:

• C1 esterase inhibitor
  • Cinryze
  • Berinert
  • Ruconest
  • Haegarda
• Selective bradykinin B2 receptor antagonist
  • Firazyr
• Kallikrein inhibitor
  • Kalbitor
• Others

By Route of Administration:

• Injection
  • Intravenous
  • Subcutaneous
• Oral

By Distribution Channel

• Hospitals
• Retail pharmacies
• Online pharmacies

Buy This Complete Business Report With Flat USD 2000 Off@ https://www.coherentmarketinsights.com/promo/buynow/1371

Reasons to Purchase This Report

• Current and future of Angioedema Treatment Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Angioedema Treatment Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Angioedema Treatment Industry Impact

Chapter 2 Global Angioedema Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Angioedema Treatment (Volume and Value) by Type
2.3 Global Angioedema Treatment (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Angioedema Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Angioedema Treatment Market Analysis
Chapter 6 East Asia Angioedema Treatment Market Analysis
Chapter 7 Europe Angioedema Treatment Market Analysis
Chapter 8 South Asia Angioedema Treatment Market Analysis
Chapter 9 Southeast Asia Angioedema Treatment Market Analysis
Chapter 10 Middle East Angioedema Treatment Market Analysis
Chapter 11 Africa Angioedema Treatment Market Analysis
Chapter 12 Oceania Angioedema Treatment Market Analysis
Chapter 13 South America Angioedema Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Angioedema Treatment Business
Chapter 15 Global Angioedema Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology